Navigation Links
Senior Regulatory Affairs and Program Management Executive, Robert Peterson, RAC, Joins NDA Partners

NDA Partners Chairman Carl Peck, MD, announced today that Robert Peterson, RAC, a regulatory affairs and program management executive with more than 33 years of regulatory and product development experience in the biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant.

Robert Peterson has extensive experience in formulating and executing regulatory, clinical, and product development strategies, interfacing with regulatory agencies, and filing regulatory submissions. In addition, he has extensive hands-on experience in research and development, manufacturing, nonclinical and clinical studies, and leading cross-functional teams in both small and large companies.

Most recently, Mr. Peterson was Executive Director of Regulatory Affairs at Liquidia Technologies Inc. He has also served as Vice President of Product Development and Regulatory Affairs at Nephrogenex Inc., Director of Research and Development at Cardiopolymers Inc., and Director of Product Development at Biostratum Inc. In his early career, he served as Director of Research and Development in the Vascular Division at Baxter Healthcare.

“Mr. Peterson’s extensive experience leading cross-functional regulatory and product development teams in both small and large companies will bring great value to our clients who need full support for their product development programs,” said Dr. Peck. “We are pleased to welcome him to NDA Partners.”

Robert Peterson earned his Master of Engineering degree in biomedical engineering from the University of California, Berkeley and his Bachelor of Science degree in engineering from the United States Military Academy at West Point, New York.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Earle Martin, Chief Executive Officer
Office: 540-738-2550

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. Tech Solutions Ready to Protect Nation’s Seniors; Zanthion Urges Nursing Facilities to Adapt
2. IBM and Avamere to Bring Cognitive Eldercare Research to Senior Living and Skilled Nursing Facilities
3. Zimmer Biomet Prices Offering of Euro-Denominated Senior Notes
4. Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference
5. Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer
6. EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables
7. Genes may thwart seniors exercise gains
8. CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago
9. In'Tech Expands Regulatory Affairs Initiative Globally to Support Its Customers Worldwide
10. VISTAAR Announces Addition of “ADVISORY Playbooks” to it’s Regulatory & Clinical Intelligence Platform
11. Regulatory Strategies for the Analytical Development of New Biological Entities and Biosimilars, New Webinar Hosted by Xtalks
Post Your Comments:
(Date:1/23/2020)... ... January 23, 2020 , ... ... new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered ... brings together a consortium of over 100 partner organizations from industry, government, ...
(Date:1/10/2020)... (PRWEB) , ... January 09, 2020 , ... ... of bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of ... lateral interbody fusion system. , The EVOL®ha-DLIF is made of PEEK-OPTIMA HA ...
(Date:1/2/2020)... FORT WORTH, Texas (PRWEB) , ... January 02, ... ... to provide custom and semi-custom aqueous reagents, chemicals, and medias, as well as ... cellular agriculture, and cell- and tissue-based product manufacturers. , “We are excited ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... SCOTCH PLAINS, N.J. (PRWEB) , ... January 24, 2020 , ... ... (IFAR) at The Plastic Surgery Center in New Jersey epitomize the notion that plastic ... plastic surgery is typically characterized in popular media. , Over the last 20 years ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO and President ... two recent North American investor forums specializing in medical advancements. New technology was ... Diagnostics Forum on November 21, 2019 in New York City, and the Aesthetic ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and Cardea Bio ... partners have agreed to co-develop and market a portfolio of CRISPR QC products ... Over the longer-term, the parties aim to develop a COBO branded QC device ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... today announced the acquisition of Cunesoft, a move that expands the company’s portfolio ... of life sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent software ...
Breaking Biology Technology: